[DIC: an application of new laboratory tests]. 1986

S Ikematsu, and M Hada, and K Kuroso, and M Arai

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000979 alpha-2-Antiplasmin A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin. alpha 2-Plasmin Inhibitor,Serpin F2,alpha(2)-Plasmin Inhibitor,alpha-2 Antiplasmin,alpha 2 Antiplasmin,alpha 2 Plasmin Inhibitor

Related Publications

S Ikematsu, and M Hada, and K Kuroso, and M Arai
January 2011, Blood reviews,
S Ikematsu, and M Hada, and K Kuroso, and M Arai
December 1986, Rinsho byori. The Japanese journal of clinical pathology,
S Ikematsu, and M Hada, and K Kuroso, and M Arai
May 1971, Southern medical journal,
S Ikematsu, and M Hada, and K Kuroso, and M Arai
July 1991, Rinsho byori. The Japanese journal of clinical pathology,
S Ikematsu, and M Hada, and K Kuroso, and M Arai
July 1991, Rinsho byori. The Japanese journal of clinical pathology,
S Ikematsu, and M Hada, and K Kuroso, and M Arai
December 2018, EJIFCC,
S Ikematsu, and M Hada, and K Kuroso, and M Arai
February 1993, Acta anaesthesiologica Scandinavica,
S Ikematsu, and M Hada, and K Kuroso, and M Arai
February 2003, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
S Ikematsu, and M Hada, and K Kuroso, and M Arai
November 1987, Rinsho byori. The Japanese journal of clinical pathology,
S Ikematsu, and M Hada, and K Kuroso, and M Arai
May 1985, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!